Clinical Trial Update: An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease. [Phase 3]

View source ↗

Summary

Open-label extension trial evaluating the safety of long-term rotigotine treatment in early-stage Parkinson's disease; the study completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Neupro (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Early-Stage Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-02-25